The trillions of microorganisms in the human intestine are important regulators of health, and
disruptions in the gut microbial communities can cause disease. The gut, liver and immune …

Nowadays, obesity is one of the most prevalent human health problems. Research from the
last 30 years has clarified the role of the imbalance between energy intake and expenditure …

NAFLD is currently the main cause of chronic liver disease in developed countries, and the
number of NAFLD patients is growing worldwide. NAFLD often has similar symptoms to …

Polycystic ovary syndrome (PCOS) is the most common endocrine disorder in young
reproductive-aged women. PCOS is often associated with obesity and impairs reproductive …

Nonalcoholic fatty liver disease (NAFLD) has rapidly become the most common form of
chronic liver disease in children and adolescents. Over the past 5 years, developments have …

Obesity is a global pandemic complex to treat due to its multifactorial pathogenesis—an
unhealthy lifestyle, neuronal and hormonal mechanisms, and genetic and epigenetic factors …

Background Hepatosteatosis is the earliest stage in the pathogenesis of nonalcoholic fatty
(NAFLD) and alcoholic liver disease (ALD). As NAFLD is affecting 10–24% of the general …

Objective To systematically review the effect of oral intake of bacterial probiotics on 15
variables related to obesity, diabetes and non-alcoholic fatty liver disease. Design …

The association between poor paternal diet, perturbed embryonic development, and adult
offspring ill health represents a new focus for the Developmental Origins of Health and …

BACKGROUND: Probiotics have a beneficial effect on nonalcoholic fatty liver disease
(NAFLD) in animal models. Randomized placebo-controlled trials (RCTs) in NAFLD are still …